(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 25.28% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.73%, and while it is forecast to beat the US market's average forecast revenue growth rate of 23.58%.
Wave Life Sciences's revenue in 2026 is $109,230,000.On average, 17 Wall Street analysts forecast WVE's revenue for 2026 to be $8,345,714,657, with the lowest WVE revenue forecast at $0, and the highest WVE revenue forecast at $17,729,628,193. On average, 15 Wall Street analysts forecast WVE's revenue for 2027 to be $19,545,222,367, with the lowest WVE revenue forecast at $5,406,658,895, and the highest WVE revenue forecast at $50,328,404,255.
In 2028, WVE is forecast to generate $37,224,696,025 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $120,772,120,762.